Development of the lipid-rich core in human atherosclerosis.
暂无分享,去创建一个
[1] Y. Hannun,et al. Programmed cell death induced by ceramide. , 1993, Science.
[2] E. B. Smith,et al. The release of an immobilized lipoprotein fraction from atherosclerotic lesions by incubation with plasmin. , 1976, Atherosclerosis.
[3] G. Shipley,et al. Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. , 1976, The Journal of clinical investigation.
[4] K. Watson,et al. Bone morphogenetic protein expression in human atherosclerotic lesions. , 1993, The Journal of clinical investigation.
[5] A. Chait,et al. Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[6] G. Schmitz,et al. Ca++ Antagonists and ACAT Inhibitors Promote Cholesterol Efflux from Macrophages by Different Mechanisms: II. Characterization of Intracellular Morphologic Changes , 1988, Arteriosclerosis.
[7] V. Tertov,et al. Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. , 1992, Circulation research.
[8] S. Rankin,et al. Role of oxidized low density lipoprotein in atherogenesis. , 1992, Progress in lipid research.
[9] J. Guyton,et al. The lipid-rich core region of human atherosclerotic fibrous plaques. Prevalence of small lipid droplets and vesicles by electron microscopy. , 1989, The American journal of pathology.
[10] W. Wagner,et al. Low density lipoprotein interaction with artery derived proteoglycan: the influence of LDL particle size and the relationship to atherosclerosis susceptibility. , 1989, Atherosclerosis.
[11] D. Steinberg,et al. Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I. , 1990, Journal of lipid research.
[12] N. Simionescu,et al. Intimal thickenings of human aorta contain modified reassembled lipoproteins. , 1995, Atherosclerosis.
[13] M. Ferguson,et al. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. , 1994, The American journal of pathology.
[14] S. Srinivasan,et al. Lipoprotein-proteoglycan complexes induce continued cholesteryl ester accumulation in foam cells from rabbit atherosclerotic lesions. , 1993, The Journal of clinical investigation.
[15] S M Schwartz,et al. Angiogenesis in human coronary atherosclerotic plaques. , 1994, The American journal of pathology.
[16] J L Witztum,et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.
[17] M J Davies,et al. Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.
[18] J. Guyton,et al. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[19] L. J. Lewis,et al. Lipoprotein Oxidation and Lipoprotein‐lnduced Cytotoxicity , 1983, Arteriosclerosis.
[20] H. Kruth,et al. Development of unesterified cholesterol-rich lipid particles in atherosclerotic lesions of WHHL and cholesterol-fed NZW rabbits. , 1994, Journal of lipid research.
[21] R. Krauss,et al. Lipolysis products promote the formation of complexes of very-low-density and low-density lipoproteins. , 1987, Biochimica et biophysica acta.
[22] E. B. Smith,et al. The lipids in raised fatty and fibrous lesions in human aorta. A comparison of the changes at different stages of development. , 1968, Journal of atherosclerosis research.
[23] H. C. Stary. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. , 1989, Arteriosclerosis.
[24] Y. Hannun,et al. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. , 1989, Science.
[25] A. Chenchik,et al. Localization of apolipoprotein E in normal and atherosclerotic human aorta. , 1990, Atherosclerosis.
[26] Kathleen M. Smith,et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Kazatchkine,et al. The complement system in atherosclerosis. , 1988, Atherosclerosis.
[28] G. Hansson,et al. Complement receptors and regulatory proteins in human atherosclerotic lesions. , 1989, Arteriosclerosis.
[29] C. Alpers,et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. , 1993, The Journal of clinical investigation.
[30] D. Morel,et al. 7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[31] P. Libby,et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.
[32] G. Camejo. The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: its possible role in atherogenesis. , 1982, Advances in lipid research.
[33] D. Falcone,et al. Fibronectin Stimulates Macrophage Uptake of Low Density Lipoprotein‐Heparin‐Collagen Complexes , 1988, Arteriosclerosis.
[34] C. W. Adams,et al. The action of human high density lipoprotein on cholesterol crystals. Part 1. Light-microscopic observations. , 1978, Atherosclerosis.
[35] D. Steinberg,et al. Enhanced Macrophage Uptake of Low Density Lipoprotein after Self‐Aggregation , 1988, Arteriosclerosis.
[36] I. Tabas,et al. Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages. , 1991, The Journal of biological chemistry.
[37] U. Steinbrecher,et al. Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[38] D. Small. The physical chemistry of lipids : from alkanes to phospholipids , 1986 .
[39] S. Schwartz,et al. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[40] J. Guyton,et al. Human Aortic Fibrolipid Lesions: Immunochemical Localization of Apolipoprotein B and Apolipoprotein A , 1988, Arteriosclerosis.
[41] A. Fogelman,et al. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. , 1989, Journal of lipid research.
[42] J. Guyton,et al. Ultrastructure of the human aortic fibrolipid lesion. Formation of the atherosclerotic lipid-rich core. , 1986, The American journal of pathology.
[43] W. J. Johnson,et al. Cholesterol transport between cells and high-density lipoproteins. , 1991, Biochimica et biophysica acta.
[44] D. Small. Cellular Mechanisms for Lipid Deposition in Atherosclerosis , 1977 .
[45] R. Mesa-Tejada,et al. Identification and Distribution of Fibrinogen, Fibrin, and Fibrin(ogen) Products in Atherosclerosis: Use of Monoclonal Antibodies , 1989, Arteriosclerosis.
[46] C. Chauzy,et al. Localization and solubilization of hyaluronan and of the hyaluronan-binding protein hyaluronectin in human normal and arteriosclerotic arterial walls. , 1994, Atherosclerosis.
[47] J. Guyton,et al. Early extracellular and cellular lipid deposits in aorta of cholesterol-fed rabbits. , 1992, The American journal of pathology.
[48] M. Mims,et al. Altered ultrastructural morphology of self-aggregated low density lipoproteins: coalescence of lipid domains forming droplets and vesicles. , 1991, Journal of lipid research.
[49] E. B. Smith,et al. The microdissection of large atherosclerotic plaques to give morphologically and topographically defined fractions for analysis. 2. Studies on "nile blue" cells. , 1972, Atherosclerosis.
[50] W. Harland,et al. Squalene, 26-hydroxycholesterol and 7-ketocholesterol in human atheromatous plaques. , 1966, Biochimica et biophysica acta.
[51] A. Fogelman,et al. An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[52] U. Steinbrecher,et al. Role of oxidatively modified LDL in atherosclerosis. , 1990, Free radical biology & medicine.
[53] G. Schmitz,et al. Ca++ Antagonists and ACAT Inhibitors Promote Cholesterol Efflux from Macrophages by Different Mechanisms: I. Characterization of Cellular Lipid Metabolism , 1988, Arteriosclerosis.
[54] V. Tertov,et al. Hydrolysis of cholesteryl ester in low density lipoprotein converts this lipoprotein to a liposome. , 1992, Journal of Biological Chemistry.
[55] J. Guyton,et al. Transitional features in human atherosclerosis. Intimal thickening, cholesterol clefts, and cell loss in human aortic fatty streaks. , 1993, The American journal of pathology.
[56] W. J. Johnson,et al. Formation of cholesterol monohydrate crystals in macrophage-derived foam cells. , 1994, Journal of lipid research.
[57] E. B. Smith,et al. The relationship between plasma and tissue lipids in human atherosclerosis. , 1974, Advances in lipid research.
[58] J. Guyton,et al. Quantitative Ultrastructural Analysis of Perifibrous Lipid and Its Association with Elastin in Nonatherosclerotic Human Aorta , 1985, Arteriosclerosis.
[59] R. A. Cooper. Abnormalities of cell-membrane fluidity in the pathogenesis of disease. , 1977, The New England journal of medicine.
[60] N. Simionescu,et al. Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. , 1986, The American journal of pathology.
[61] G. Rothblat,et al. Triglyceride and cholesteryl ester hydrolysis in a cell culture model of smooth muscle foam cells. , 1989, Journal of lipid research.
[62] O. Portman,et al. Hydrolysis of cholesteryl linoleate by a high-speed supernatant preparation of rat and monkey aorta. , 1966, Biochimica et biophysica acta.
[63] B. Halliwell,et al. Lipids and oxidised lipids in human atheroma and normal aorta. , 1993, Biochimica et biophysica acta.
[64] T. Bocan,et al. Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological, and morphometric evaluation. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[65] J. Guyton,et al. Human aortic fibrolipid lesions. Progenitor lesions for fibrous plaques, exhibiting early formation of the cholesterol-rich core. , 1985, The American journal of pathology.
[66] J L Witztum,et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.
[67] G. Hansson,et al. Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[68] W. Hollander,et al. Soluble proteins in the human atheroschlerotic plaque , 1979 .
[69] C. V. Smith,et al. Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein. , 1990, Journal of lipid research.
[70] R. Tangirala,et al. Lysosomal accumulation of unesterified cholesterol in model macrophage foam cells. , 1993, The Journal of biological chemistry.
[71] A. Daugherty,et al. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.
[72] H. Rus,et al. Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque. , 1986, Atherosclerosis.
[73] H. Kruth,et al. Localization of unesterified cholesterol in human atherosclerotic lesions. Demonstration of filipin-positive, oil-red-O-negative particles. , 1984, The American journal of pathology.
[74] Y. Zhang,et al. Plasma protein insudation as an index of early coronary atherogenesis. , 1993, The American journal of pathology.
[75] G. Hutchins,et al. The relationship between coronary artery lesions and myocardial infarcts: ulceration of atherosclerotic plaques precipitating coronary thrombosis. , 1977, American heart journal.
[76] R. Sato,et al. Monoclonal antibody EMR1a/212D recognizing site of deposition of extracellular lipid in atherosclerosis: purification and characterization of the antigen. , 1989, The American journal of pathology.
[77] M. Davies,et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. , 1993, British heart journal.
[78] W D Wagner,et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Circulation.
[79] M. Bond,et al. Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. , 1990, The American journal of pathology.
[80] R. Tracy,et al. Variations in human aortic fatty streaks among geographic locations. , 1975, Atherosclerosis.
[81] S. Srinivasan,et al. Lipoprotein-hyaluronate associations in human aorta fibrous plaque lesions. , 1980, Atherosclerosis.
[82] T. E. Whitaker,et al. Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition. , 1992, The Journal of biological chemistry.
[83] J. Resau,et al. Unesterified cholesterol-rich lipid particles in atherosclerotic lesions of human and rabbit aortas. , 1988, The American journal of pathology.
[84] H. Kruth. Subendothelial accumulation of unesterified cholesterol. An early event in atherosclerotic lesion development. , 1985, Atherosclerosis.
[85] P. Kovanen,et al. Modification of low density lipoproteins by secretory granules of rat serosal mast cells. , 1991, The Journal of biological chemistry.
[86] I. Tabas,et al. Regulation of the threshold for lipoprotein-induced acyl-CoA:cholesterol O-acyltransferase stimulation in macrophages by cellular sphingomyelin content. , 1994, Journal of lipid research.
[87] R. Wissler,et al. A study of the immunohistochemical localization of serum lipoproteins and other plasma proteins in human atherosclerotic lesions. , 1965, Experimental and molecular pathology.
[88] C. W. Adams,et al. The action of human high density lipoprotein on cholesterol crystals. Part 2. Biochemical observations. , 1978, Atherosclerosis.
[89] G. Anantharamaiah,et al. Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[90] J. Anderson,et al. Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas. , 1992, The American journal of pathology.
[91] M. J. Mitchinson,et al. Insoluble lipids in human atherosclerotic plaques. , 1982, Atherosclerosis.
[92] A. Fogelman,et al. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[93] J. Guyton,et al. Development of the atherosclerotic core region. Chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[94] W. J. Johnson,et al. Cell Toxicity Induced by Inhibition of Acyl Coenzyme A:Cholesterol Acyltransferase and Accumulation of Unesterified Cholesterol * , 1995, The Journal of Biological Chemistry.
[95] C. Böttcher,et al. Changes in the composition of phospholipids and of phospholipid fatty acids associated with atherosclerosis in the human aortic wall , 1961 .
[96] A. Gotto,et al. Correlation of apolipoprotein B retention with the structure of atherosclerotic plaques from human aortas. , 1978, Laboratory investigation; a journal of technical methods and pathology.
[97] M. Brown,et al. Stimulation of Cholesteryl Ester Synthesis in Macrophages by Extracts of Atherosclerotic Human Aortas and Complexes of Albumin/Cholesteryl Esters , 1981, Arteriosclerosis.
[98] M. Medow,et al. Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells. , 1991, Circulation research.
[99] J. Resau,et al. Characterization of two unique cholesterol-rich lipid particles isolated from human atherosclerotic lesions. , 1990, The American journal of pathology.
[100] Qingbo Xu,et al. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. , 1993, The American journal of pathology.
[101] Reynolds Gd,et al. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. , 1987 .
[102] A. Chait,et al. Phagocytosis of lipase-aggregated low density lipoprotein promotes macrophage foam cell formation. Sequential morphological and biochemical events. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.